ロード中...
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women
BACKGROUND: Tamoxifen can reduce the risk of developing invasive estrogen-receptor positive (ER+) breast cancer by 49%, but it is unknown how many women in the U.S. are taking tamoxifen for primary prevention of breast cancer. METHODS: Data from the years 2000 and 2005 National Health Interview Surv...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3038785/ https://ncbi.nlm.nih.gov/pubmed/20142242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-09-0930 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|